Buda Juice (BUDA) investor relations material

Executive summary

• Q3 2026 revenue reached a record $5.2 million, up 64% YoY; core beverage same-store sales rose 23%.

• Adjusted EBITDA increased 35% YoY to $1.306 million; gross margin improved 417 bps QoQ to 40.8%.

• Growth reflected stronger sales in existing stores, expanded retail distribution and the refrigerated dressings business.

Financial highlights

• Revenue was $5.2 million versus $3.2 million in Q3 2025; gross profit increased 51% YoY to $2.1 million.

• Operating expenses were $1.1 million, or 21.7% of revenue, versus $0.5 million, or 17.0%, YoY; the ratio improved ~510 bps sequentially.

• Net income was $866,000, or $0.07 per diluted share, essentially flat YoY; pre-tax income was $1.140 million.

• 9M revenue was $13.223 million versus $9.714 million; 9M net income was $1.724 million versus $2.858 million.

• Q3 operating cash flow was approximately $710,000.

Outlook and guidance

• Refrigerated dressing production is expected to transition in-house at the Dallas facility in Q1 2027, targeting better efficiency and recovery of co-packing costs.

• Priorities include increasing velocity and assortment with existing retailers, expanding where demand and economics support it, and investing in production and distribution with discipline.

• East Coast expansion is a longer-term goal; a new facility would depend on confirmed customer demand, with expansion hoped for next year.

• Capacity, product innovation and Fresh35° cold-chain infrastructure investments are intended to support retail expansion; regional facilities are contemplated over time for short-shelf-life products.